<DOC>
	<DOCNO>NCT01802788</DOCNO>
	<brief_summary>Further assess performance safety profile commercially available Portico Valve implant , use Delivery System Loading System , patient severe symptomatic aortic stenosis .</brief_summary>
	<brief_title>5 Year Observation Patients With PORTICO Valves</brief_title>
	<detailed_description />
	<mesh_term>Aortic Valve Stenosis</mesh_term>
	<criteria>Patient sign Patient Informed Consent prior participate clinical investigation . Patient refer Portico Valve implant per Heart Team decision . Patient senile degenerative aortic stenosis initial valve area le ( &lt; ) 1.0 cm2 ( aortic valve area index less equal ( â‰¤ ) 0.6 cm2/m2 ) AND mean transvalvular gradient great ( &gt; ) 40mmHg jet velocity great ( &gt; ) 4.0 m/s derive rest echocardiogram [ dobutamine stress echocardiogram subject leave ventricular ejection fraction ( LVEF ) &lt; 50 % ] . ( Baseline measurement take echo within 45 day index procedure ) . Patient life expectancy ( &gt; ) 12 month . Any case Portico Valve would indicate patient per current instruction use ( i.e `` offlabel '' use ) . Patient tricuspid valve . Patient prosthetic valve ring aortic position . Patient need concomitant structural heart procedure . Patient need usage embolic protection device . Patient unwilling unable comply clinical investigationrequired followup evaluation . Patient pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Aortic Stenosis</keyword>
	<keyword>Heart Valve Prosthesis</keyword>
	<keyword>Trans Catheter Aortic Valve Replacement</keyword>
	<keyword>TAVR</keyword>
	<keyword>Trans Catheter Aortic Valve Implant</keyword>
	<keyword>TAVI</keyword>
</DOC>